New Directions: The Trump Administration

Strategic insights and guidance for businesses navigating shifts in US policy and regulation.

Our interdisciplinary team has decades of experience helping businesses navigate major transitions. We monitor federal developments and provide timely analysis to help companies stay ahead of change. As the new administration takes shape, we will work closely with companies across sectors to help them understand and respond to new federal priorities and state actions, positioning them to address challenges and seize opportunities.

DOJ Takes Aim at Private Sector DEI and DEIA Policies

The agency signaled that it intends to use the force of criminal investigations to eliminate certain practices in the private sector.

SEC Outlook: Potential Updates Under Nominated Chairman Atkins

With pending rules that may affect digital assets, ESG disclosures, service provider oversight, trading, and other areas, how will SEC Chairman nominee Paul Atkins approach leftovers of the prior administration’s agenda?

How Should Public Companies Approach Disclosures in 2025?

In this audio discussion, we cover disclosure considerations for companies navigating policy shifts as they prepare annual reports and proxy statements.

DoD Moves to Cancel DEI Contracts Under Trump EO

New memo directs immediate termination of diversity-related contracts and requires reporting of all DEIA agreements by February 21, 2025.

Tax Reform and the Trump Administration

Major tax changes loom in 2025 as the administration weighs extensions and new proposals.

Environmental Regulations and Climate Initiatives: A Targeted Rollback

An overview of outcomes from environment and climate actions taken by the president.

On His Eighth Day in Office, President Trump Gave to Me Memorandum No. M-25-13

The potential implications of the memoranda are far-reaching, despite legal challenges. 

Trump 2.0 Week 1 Tech Policy Rundown: Pivot on AI but Data Rules Stand

The new administration signals dramatic shift in AI policy, but rules on children’s and other sensitive data largely remain in place. 

President Trump Issues Executive Order Targeting Policies and Practices Designed to Ensure Equal Opportunity

The order overhauls the government’s approach to combating discrimination and ensuring equal opportunities. 

Trump Signs Executive Order Outlining Pro-Crypto Policy

The order sets forth the policy of the administration as supporting, protecting, and promoting digital asset and blockchain technologies.

Executive Order Mandates Termination of DEI Related Federal Contracts and Grants

The intention is to terminate all DEI and DEIA mandates, policies, programs, preferences, and activities in the federal government.

Changes Expected as Trump Administration Continues to Take Shape

Ten areas where anticipated policy shifts could significantly affect clients and their businesses.

How the Trump Administration Could Reshape Regulation in Life Sciences

Emerging policy suggest significant changes for biotech, pharmaceutical, and medical device companies.

Selected Areas of Focus

Our Antitrust & Competition team has unparalleled expertise in handling the full range of antitrust matters for our clients, from merger clearance to complex litigation.

Learn more about our Antitrust & Competition group.

Contact: Arman Oruc

Our Artificial Intelligence & Machine Learning team works with innovators and investors to advance their AI objectives while steering clear of the risks. We help ensure that companies use AI in ways that minimize IP, data privacy and other regulatory issues.

Learn more about our Artificial Intelligence & Machine Learning group.

Contact: Omer Tene

Our Employment team supports clients with the employment aspects of domestic and cross-border transactions, develops and negotiates employment and compensation agreements, conducts employment investigations, and represents clients throughout the litigation process.

Learn more about our Employment group.

Contact: Christina Lewis

Our top-ranked Data, Privacy & Cybersecurity practice is one of the longest-standing of any Am Law 50 firm. Across the United States and Europe, our specialists include former federal prosecutors, assistant US attorneys, and experienced legal professionals in every aspect of global privacy and cybersecurity law.

Learn more about our Data, Privacy, & Cybersecurity group.

Contacts: Pete Marta, Omer Tene

Our global team of highly regarded advisors has expertise in every area affecting players in the digital currency and digital asset spaces. We embrace the potential of innovation to make lasting impact, and we partner with companies that are shaping the future of digital currency and blockchain in rapidly developing areas.

Read about key litigation and enforcement developments: “Digital Currency & Blockchain 2024 Year End Review

Learn more about our Digital Currency & Blockchain group.

Contacts: Grant Fondo, Karen Ubell

We help clients achieve long-term success by developing strategies and implementing solutions that meet evolving regulatory and social expectations, advance goals for impact and responsible investing, and generate superior long-term returns.

Learn more about our ESG Impact group.

Contact: Danielle Reyes

Our practice includes attorneys with expertise in every segment of financial services and relevant practice area, from transactions, regulatory and advisory (including the Corporate Transparency Act), enforcement, and litigation.

Learn more about our Financial Services group.

Contact: Samantha Kirby

We advise US and international companies that receive grants from or sell goods and services to federal and state agencies and tribal governments in the US. We represent companies in all aspects of the procurement process, including bidding on and negotiating contracts and grant awards with federal agencies.

Learn more about our Government Contracts & Grants group.

Contact: Liza Craig

Our team focuses on the needs of stakeholders in the pharmaceutical, biologic, medical device, diagnostic, laboratory testing, and digital health industries. We provide strategic counseling at every step in the medical product lifecycle, from idea conception and product development to commercialization. That includes advising on clinical trials, FDA approval and clearance, market access, reimbursement, and customer contracts.

Learn more about our Life Sciences Regulatory & Compliance group.

Contact: Matt Wetzel

Combining first-chair trial expertise, business acumen, and deep regulatory experience, we have a distinguished track record defending clients in qui tam and False Claims Act investigations and cases, efficiently responding to Civil Investigatory Demands, as well as leading internal fraud and abuse investigations. When federal or state governmental enforcement matters arise, our life-science and healthcare enforcement team — comprised of high-level former federal prosecutors and government officials — works closely with our regulatory specialists to advocate and litigate against DOJ, HHS-OIG, CMS, FDA, and state AG MFCUs, when the need arises. Unlike many other firms, we try cases to win and have achieved successful jury verdicts of full acquittal for professionals as well as senior leadership and management. Finally, we have represented numerous private equity investors and consultants who have been wrongfully embroiled in governmental investigations.

Learn more about our Government Investigations, Enforcement & White Collar Defense group.

Contact: Allan Medina

We are a global leader in mergers and acquisitions, providing highly differentiated strategic and commercial advice and top-tier execution on more transactions annually than any other firm in the world. We represent clients in transactions of all kinds, including their most important and complex international deals. That includes public and private companies, private equity and venture capital firms, and founders, as well as financial advisors and investors.

Learn more about our Mergers & Acquisitions group.

Contact: Mike Patrone

Our Public Company Advisory team advises hundreds of US and non-US public companies, as well as private companies seeking to go public, on SEC and corporate governance issues, including SEC regulatory and disclosure requirements and stock exchange listing compliance.

Learn more about our Public Company Advisory group.

Contact: Dave Lynn

We advise private equity, real estate, life sciences, and technology clients on how to structure their transactions to achieve optimal tax outcomes. This includes advising on company formation, taxable and tax-free M&A, recapitalizations, real estate transactions, investment fund formations, research and development joint ventures, tech transfers, leveraged buyouts, partnership transactions, and private and public securities offerings.

Learn more about our Tax group.

Contact: Neal Sandford

We help companies involved in cross-border transactions to navigate regulatory hurdles relating to the export and re-export of sensitive goods and technologies; investments and other dealings having national security implications; and relationships with persons and entities that may be governed by US economic sanctions, anti-money laundering and anti-corruption laws.

Learn more about our Global Trade group.

Contact: Rich Matheny